Community
2026/7/31
Healthcare AI Moves Beyond Information Retrieval
Recent studies highlight a major shift in healthcare AI—from answering medical questions to recognizing disease risks earlier, improving diagnostic safety, and accelerating scientific discovery. Frontier large language models now outperform specialized clinical AI tools on multiple medical benchmarks, while new real-world studies show AI can identify missed diagnostic opportunities and help detect rare diseases earlier. At the same time, medicine is evolving into an information industry powered by AI, and agentic AI is beginning to generate new biological insights for cancer research. These advances support our vision that AI-native Learning Health Systems can help patients and caregivers recognize disease risks earlier and continuously improve healthcare.
2025/12/15
At the Chen Institute’s AI Accelerated Science Symposium on October 28, 2025, ELHS Institute founder Dr. AJ Chen proposed a new vision for Open Clinical AI Science (OCAIS) to accelerate the clinical impact of generative AI. The framework delivers free GenAI-based disease prediction services to clinical teams worldwide, including low-resource settings, enabling large-scale participation in clinical evidence generation. By converging GenAI with task-specific Learning Health System units, this approach aims to shorten evidence-generation timelines from decades to years and help prevent GenAI from repeating past failures in health care innovation.
2025/10/25
Dr. AJ Chen delivered a keynote at the Tsinghua Health AI Summit on converging generative AI (GenAI) and Learning Health Systems (LHS) to improve clinical diagnosis and reduce global health disparities. He presented the ELHS Institute’s ML-enabled LHS framework, supported by Nature- and JAMIA-published studies, showing how GenAI embedded in LHS units can enable scalable, responsible evidence generation and democratize high-standard predictive care worldwide.
